ΔN-p73 is a transcriptional target of the PML/RARα oncogene in myeloid differentiation [1]

Cell Death and Differentiation

Volumn 14, Issue 11, 2007, Pages 1968-1971

  Mainardi, S ^a   Pelosi, A ^a   Palescandolo, E ^b   Riccioni, R ^c   Fontemaggi, G ^a,d   Diverio, D ^b   Testa, U ^c   Sacchi, A ^a   Grignani, F ^e   Lo Coco, F ^f   Levrero, M ^a,b,d   Blandino, G ^a,d   Rizzo, M G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Rome Oncogenomic Center   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CAMPTOTHECIN; CD11B ANTIGEN; CD15 ANTIGEN; CYTOCHROME C; DEOXYRIBONUCLEASE I; DNA FRAGMENT; ENDONUCLEASE; ETOPOSIDE; GLYCOPROTEIN P 15095; HYBRID PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P73; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TP73 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

BINDING SITE; BONE MARROW CELL; BREAST CANCER; CELL DAMAGE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; LETTER; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY SEQUENCE; RNA INTERFERENCE; SEQUENCE ANALYSIS; DRUG ANTAGONISM; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MYELOPOIESIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MOLECULAR SEQUENCE DATA; MYELOPOIESIS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 35548960063     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402210     Document Type: Letter

References (10)

1. Giombini E et al. Gene Ther Mol Biol 2005; 9: 377-392.
2. Grob TJ et al. Cell Death Differ 2001; 8: 1213-1223.
3. Kawano S et al. Blood 1999; 94: 1113-1120.
4. Rizzo MG et al. Leukemia 2004; 18: 1804-1808.
5. Tschan MP et al. Biochem Biophys Res Commun 2000; 277: 62-65.
6. Jing Y. Leuk Lymphoma 2004; 45: 639-648.
7. DiCroce L et al. Science 2002; 295: 1079-1082.
8. Belloni L et al. Oncogene 2006; 25: 3606-3612.
9. Saifudeen Z et al. J Biol Chem 2005; 280: 23094-23102.
10. Lanza M et al. Cell Cycle 2006; 5: 1996-2004.